320-x-100_uti_gold.jpg" alt="Advertisement">
Neutral - Kilitch Drugs (INDIA) Ltd Book Profit For Target Rs.238 - Sushil Finance
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
BOOK PROFITS & RATING CHANGED TO NEUTRAL
We had initiated coverage on Kilitch Drugs (India) Ltd on November 01, 2021 at an initiation price of Rs. 164 and a target price of Rs. 238. We are changing our recommendation to neutral as the stock has achieved our initial price objective. Hence, we recommend that short term investors can book profits, whereas, long terminvestors can continue to hold.
To Read Complete Report & Disclaimer Click Here
Please refer disclaimer at https://www.sushilfinance.com/Disclamier/disclaimer
Member : BSE/ NSE/ MSEI. SEBI Registration No.-INZ000165135.
Above views are of the author and not of the website kindly read disclaimer
